CDK4/6抑制剂与乳腺癌，从转移到佐剂:临床资料

{"title":"CDK4/6抑制剂与乳腺癌，从转移到佐剂:临床资料","authors":"","doi":"10.1684/ito.2022.0317","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":318256,"journal":{"name":"Innovations & Thérapeutiques en Oncologie","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inhibiteurs de CDK4/6 et cancers du sein, du métastatique à l’adjuvant : données cliniques\",\"authors\":\"\",\"doi\":\"10.1684/ito.2022.0317\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":318256,\"journal\":{\"name\":\"Innovations & Thérapeutiques en Oncologie\",\"volume\":\"8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovations & Thérapeutiques en Oncologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1684/ito.2022.0317\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations & Thérapeutiques en Oncologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1684/ito.2022.0317","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}